Objective: To report a case of Chronic Lymphoid Leukemia in a 28-year-old young
subject, with variable clinical features and a TP53 mutation, diagnosed and
followed up in the Onco-Hematology department of the HNN. Observation: 28-year-old patient, having consulted for polyadenopathy and physical asthenia,
whose clinical examination found a conscious patient, submaxillary,
laterocervical, axillary and inguinal lymphadenopathy, bilateral, symmetrical,
painless and non-compressive whose largest measures 3 cm in diameter.
Hepato-splenomegaly and epistaxis. Predominantly lymphocyte hyperleukocytosis,
immunophenotyping revealed low CD19+, CD5+, CD23+, CD20 monoclonal B lymphoid
proliferation. The Matutes score was 4. A karyotype showed a three-chromosome
translocation; the short arm of achromosome 2, the long arm of a chromosome 11 and the long
arm of a chromosome 13, and a translocation between the long arm of a chromosome 6 and the long arm of a chromosome 18. A FISH
objectified a led 17p. The diagnosis of Binet Stage C CLL with positive del 17p and complex karyotype was
retained. Despite the poor prognosis, the R-C (Rituximab-Chlorambucil) protocol
was instituted with once-weekly transfusions. The patient is still alive in
partial clinical and biological remission. Conclusion: Despite
therapeutic progress, the presence of the deletion of chromosome 17p with TP53
mutation and the young age of the patient does not change the patient’s
prognosis.
References
[1]
Ficher, R.I., LeBlanc, M., Press, O.W. and Maloney , D.G., Unger, J.M. and Miller, T.P. (2005) New Treatment Options have Changed the Survival of Patients with Follicular Lymphoma. Journal of Clinical Oncology, 23, 8447-8452. https://doi.org/10.1200/JCO.2005.03.1674
[2]
Michael, G., et al. (2018) Recommendations for the Diagnosis and Treatment of Chronic Lymphocytic Leukemia in Switzerland. Forum Médical Suisse, 11, 93-97.
[3]
Malam, A.B., Brah, S., Djibrilla, A., Andia, A., Cheffou, M., Mahaman Sani, M.A. et al. (2018) Chronic Lymphocytic Leukemia in Niger, a Study of 99 Cases in the Onco-Hematology Department of the National Hospital of Niamey. Health Sciences and Disease, 19, 93-96. http://www.hsd-fmsb.org/
[4]
Helene, M.-B. (2006) Leucémie lymphoïde chronique: Biologie et prognostic [Chronic Lymphocytic Leukemia: Biology and Prognosis]. Revue Francophone des Laboratoires, 2006, 37-43. https://doi.org/10.1016/S1773-035X(06)80080-8
[5]
Amira, M., Bouzidi, N., Damak, M. and Mhiri, C. (2017) Neuro-myélite optique révélant une leucémie lymphoïde chronique [Neuro-Myelitis Optica Secondary to Chronic Lymphoid Leukemia]. Journal Français d’Ophtalmologie, 40, 219-221. https://doi.org/10.1016/j.jfo.2016.05.013
[6]
Bernadette, A., et al. (2011) Infiltration of the Renal Parenchyma by Chronic B Lymphoid Leukemia with Plasma Cell Differentiation and Renal Failure: A Rare Possibility in Nephropathology. Literature Review about a Case. Néphrologie & Thérapeutique, 7, 479-487.
[7]
Boudin, L., Patient, M., Roméo, E., Bladé, J.-S., Gisserot, O. and de Jauréguiberry, J.-P. (2017) Acquired, Non-Amyloid Related Factor X Deficiency: A First Case Associated with Atypical Chronic Lymphoid Leukemia and Literature Review. La Revue de Médecine Interne, 38, 478-481. https://doi.org/10.1016/j.revmed.2016.12.003
[8]
Casassa, E.A., et al. (2017) Herpès chronique périnéal résistant à l’aciclovir révélateur d’une leucémie lymphoïde chronique [Acyclovir-Resistant Perineal HSV Infection Revealing Chronic Lymphoid Leukaemia]. Annales de Dermatologie et de Vénéréologie, 145, 182-186. https://doi.org/10.1016/j.annder.2017.10.013
[9]
Vlachonikola, E., Stamatopoulos, K. and Chatzidimitriou, A. (2018) T Cells in Chronic Lymphocytic Leukemia: A Two-Edged Sword. Frontiers in Immunology, 11, Article 612244.
[10]
Lucile, J. (2010) Biological and Prognostic Management of Chronic Lymphocytic Leukemia. Annales de Biologie Clinique, 74, 45-49.
[11]
Nguyen-Khac, F., Borie, C., Callet-Bauchu, E., Eclache, V. and Struski, S. (2016) Place de la cytogénétique dans la prise en charge de la leucémie lymphoïde chronique: Actualisation du Groupe francophone de cytogénétique hématologique (GFCH) [Role of Cytogenetics in the Management of Chronic Lymphoid Leukemia: Update of the French-Speaking Group of Hematological Cytogenetics (GFCH)]. Annales de Biologie Clinique, 74, 561-567. https://doi.org/10.1684/abc.2016.1177
[12]
Leblond, V. (2012) Chronic Lymphocytic Leukemia in the Elderly. The Journal of Internal Medicine, 33S, A18-A20.